Company Filing History:
1 out of 1 
1 out of 1 
1 out of 4,447 
Years Active: 2010-2024
Title: David John Stokell: Innovator in Biopharmaceuticals
Introduction
David John Stokell is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of three patents. His work primarily focuses on advancements in antibody technology and insulin production methods.
Latest Patents
Stokell's latest patents include innovative developments in human interleukin-4 receptor alpha antibodies. This patent relates to antibodies that specifically bind to human IL-4Rα, along with compositions and methods for utilizing these antibodies. Another significant patent involves novel proinsulin constructs and insulin production methods. This invention features proinsulins and proinsulin analogs with specific modifications that enhance insulin production processes, ultimately leading to improved therapeutic preparations.
Career Highlights
Throughout his career, Stokell has worked with prominent companies in the biotechnology sector. Notable among these are Elona Biotechnologies and Stelis Biopharma Private Limited. His work in these organizations has contributed to the advancement of biopharmaceutical technologies.
Collaborations
Stokell has collaborated with several professionals in his field, including Ronald E. Zimmerman and Michael Patrick Akers. These collaborations have further enriched his research and development efforts.
Conclusion
David John Stokell is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in antibody technology and insulin production. His contributions continue to impact the field positively.